Press release
Phenylbutazone Market Plying for Significant Growth During 2017 - 2025
Phenylbutazone can be administered intravenously or orally (via powder, paste or feed-in). Phenylbutazone should not be injected in any place other than a vein and administered intramuscularly. Edema and tissue damage may also occur if the drug is injected repetitively into the same vein. Side effects of phenylbutazone include blood dyscrasia, GI ulcers, oral lesions, kidney damage and internal hemorrhage. Phenylbutazone should not be used in combination with vitamin K antagonists such as warfarin as it amplifies the anticoagulant effect of these drugs. Phenylbutazone displaces warfarin from toxic blood levels and plasma binding sites leading to haemorrhage.
Request Report For TOC @ https://www.persistencemarketresearch.com/toc/20644
The growth in end user industries is expected to increase demand for phenylbutazone. The growth in veterinary medicine industry is expected to increase consumption of phenylbutazone. In addition, rising demand for non steroidal anti-inflammatory drugs from emerging economies of Asia Pacific and Latin America is expected to boost demand for phenylbutazone. However, availability of substitutes and government regulations could hamper the growth of this market. Harpagophytum can replace phenylbutazone for treatment of fever and pain in horses.
Asia Pacific is expected to be the largest consumer of phenylbutazone followed by North America and Europe. China and India are the major consumers of phenylbutazone in Asia Pacific due to presence of established end user industries. Phenylbutazone manufacturers are shifting their base to emerging economies of Asia Pacific due to availability of government subsidies, land and cheap labor. Mongolia, Republic of Korea, Australia and New Zealand are expected to be other major consumers of phenylbutazone in Asia Pacific. North America and Europe are expected to experience moderate to high growth. In addition, demand for phenylbutazone is expected to increase in emerging economies of Latin America due to increasing demand for veterinary drugs. Argentina, Brazil, Colombia and Peru are major consumers of phenylbutazone in Latin America.
The market is dominated by large and medium chemical and pharmaceutical corporations. Some of the key players in this market are Santa Cruz Biotechnology, Inc. (U.S.), Hangzhou Hyper Chemicals Limited (China), Baoji Guokang Bio-Technology Co., Ltd.(China), Wuhan Yitongtai Science and Technology Co., Ltd. (China), Afine Chemicals Limited (china), Shanghai Win-Win Biochemical Co., Ltd. (china), Shaanxi TOP Pharm Chemical Co., Ltd.(China), Hangzhou Hyper Chemicals Limited (China), Hangzhou Ruijiang Chemical Co., Ltd. (China), Dalian Launcher Fine Chemical Co., Ltd.(China), Croma Life Science Pvt. Ltd (India), Swati Chemicals (India), Suchem Laboratories (India), Uni-med India (India), Afton Pharma (India) and Hefei TNJ Chemical Industry Co., Ltd. (China) among others. Companies are using strategic acquisitions and mergers to remain competitive in the market. In addition, companies are increasing their presence in emerging economies of Latin America and Europe to increase their market presence.
Request To Sample Of Report @ https://www.persistencemarketresearch.com/samples/20644
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Phenylbutazone Market Plying for Significant Growth During 2017 - 2025 here
News-ID: 924768 • Views: …
More Releases from Persistence Market Research
Automotive MRO Industry Forecast to Hit US$ 171.3 Billion by 2032, Advancing at …
The global Automotive MRO (Maintenance, Repair, and Operations) market is experiencing steady growth, driven by the increasing need for vehicle maintenance services and aftermarket support across passenger and commercial vehicles. According to Persistence Market Research, the market is expected to reach a value of US$171.3 Bn by 2032, up from US$126.7 Bn in 2025, reflecting a CAGR of 4.4% during the forecast period of 2025 to 2032. The market growth…
Global Automotive Horn Industry Forecast at US$3.3 Billion by 2032, Led by Compa …
The automotive horn market plays a crucial yet often understated role in the global automotive ecosystem, serving as a primary safety and communication component across vehicle categories. Automotive horns are mandated safety devices designed to alert pedestrians, cyclists, and other vehicles, thereby reducing the risk of collisions in diverse traffic environments. As global vehicle production and on-road vehicle density continue to rise, the relevance of reliable and effective horn systems…
Aircraft Flight Control System Market to Hit US$ 45.7 Billion by 2033 as Key Pla …
The Aircraft Flight Control System Market represents a critical pillar of the global aerospace and aviation ecosystem, enabling safe, efficient, and precise aircraft operations across commercial, military, and general aviation platforms. Flight control systems are responsible for managing aircraft stability, maneuverability, and responsiveness by translating pilot or automated inputs into aerodynamic actions. As aviation technology continues to evolve, these systems have transformed from purely mechanical assemblies into highly integrated digital…
U.S. & Canada Bicycle Accessories Market to Hit US$3.7 Billion by 2033 as Key Pl …
The U.S. & Canada bicycle accessories market is undergoing a notable transformation as cycling continues to gain traction as a preferred mode of transportation, fitness activity, and recreational pursuit. Changing urban mobility patterns, increasing focus on personal health, and a growing emphasis on eco-friendly transportation are reshaping the demand landscape for bicycle accessories across North America. From safety gear and lighting systems to advanced smart accessories, the market is evolving…
More Releases for Phenylbutazone
Phenylbutazone Manufacturing Plant Project Report 2023: Industry Trends, Raw Mat …
IMARC Group's report titled "Phenylbutazone Manufacturing Plant Project Report 2023: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a phenylbutazone manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the…
Phenylbutazone Market – Notable Developments, Upcoming Trends & Future Applica …
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
Global Phenylbutazone Market Huge Growth Opportunity between 2020-2025
LP INFORMATION recently released a research report on the Phenylbutazone market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Phenylbutazone market by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Phenylbutazone market, market definition, overview, industry opportunities and trends, investment strategy…
Phenylbutazone Market Region-wise Outlook of 2025 - Santa Cruz Biotechnology, In …
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
Phenylbutazone Market is Expected to Witness Highest Growth During 2017 - 2025
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
Phenylbutazone Market Detailed Analysis and Forecast by 2025
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
